- Reaction score
- 122
"Both indications of androgenetic alopecia and acne vulgaris have huge unmet clinical needs. According to animal experiments, the efficacy of GT20029 is superior to other small molecule AR inhibitors"Their doses tested in mice were 0.4, 0.8, 1.6 and 3.2%. It performed equal to minoxidil 5%.
For acne (sebum/gland reduction) it was actually outperformed by Breezula on hamsters xD
liars
but if it is not superior to pyrilutamide y woukd they, even trial it and spend money on it?
also the only reason for this to not completely outperform anything else must be absorption. if all the ARs were degraded, it is virtually impossible for any androgenic action to take place. it seems that this compound fails to do so even thoifh they claimes it stays in tissue long after application, yad yada.
it is not the time to be hopeful about anything tbh.
thankfully by 2029 Dr nagasaki from Tokio will start his trial on white mice with an-al finasteride. that is something to look forward to. go Dr nagasaki, go a-nal finasteride